Pioneering Genomic Progress: An Interview with Rami Mehio, Illumina’s Software and Informatics Expert

In this interview, Rami Mehio, head of software and informatics at Illumina, shares his experiences and contributions to major genomic projects like the UK Biobank’s whole genome sequencing. He discusses the challenges and innovations in genomic data analysis, highlighting Illumina’s role in advancing genetic research and precision medicine.

SGLT2 Inhibitors May Slow Nonsevere Aortic Stenosis Progression

SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis. After adjustments, patients on SGLT2 inhibitors had a significantly reduced risk of progression to

February 20, 2025

The biotech scorecard for the third quarter: 15 stock-moving events to watch

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Novo Nordisk is conducting a large clinical trial to

July 3, 2023

FDA approves first-ever adolescent alopecia treatment from Pfizer – Pharmaceutical Technology

Pfizer’s Litfulo is one of the first approved treatments for an often neglected disease. Source: Shutterstock / meyer_solutions. The US Food and Drug Administration (FDA)

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.